Device type · OYX
Bcr/Abl1 Monitoring Test
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OYX
Pathology
Device class
Class II
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
1
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Bcr/Abl1 Monitoring Test
- Product code
- OYX
- Device class
- Class II
- Review panel
- Pathology
- Regulation
- 21 CFR 866.6060
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for OYX
Latest FDA decisions
K252243 · Decided Jul 2, 2026 · 349 days after receipt
Device type: Bcr/Abl1 Monitoring Test (OYX) · Laboratory Medicine & Pathology
Suzhou Sniper Medical Technologies Co., Ltd.
K221869 · Decided Sep 5, 2023 · 434 days after receipt
Device type: Bcr/Abl1 Monitoring Test (OYX) · Laboratory Medicine & Pathology
- Xpert BCR-ABL Ultra, GeneXpert Dx System, GeneXpert Infinity-48s and GeneXpert Infinity-80 Systems510(k)
K190076 · Decided Sep 27, 2019 · 254 days after receipt
Device type: Bcr/Abl1 Monitoring Test (OYX) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Reports received
1
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 1 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 0 | 0 | 0 |
| Apr 25 | 1 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 2 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 0 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Negative Result1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions1
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0959-2026 · Started Oct 30, 2025 · Posted by FDA Dec 18, 2025
Reason given: Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.
Cause as FDA categorized it: Process design
Z-0960-2026 · Started Oct 30, 2025 · Posted by FDA Dec 18, 2025
Reason given: Invitro diagnostic test kits with specimens that have elevated white blood cell count (>30,000 cell) may cause inaccurate results.
Cause as FDA categorized it: Process design
- Bio-Rad, REF: 12005660, QXDx BCR-ABL %IS KitOpen, Classified
Z-1358-2024 · Started Feb 15, 2024 · Posted by FDA Mar 22, 2024
Reason given: Due to incorrect calibrations and controls, their is a potential of incorrect reporting of lower %IS and molecular response values.
Cause as FDA categorized it: Nonconforming Material/Component
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.